To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 39,516 shares, the number of shares held increased 0.37% compared to the previous period and now represents 0.84% of the total position.
      7.23K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 27,930 shares, the number of shares held increased 0.37% compared to the previous period and now represents 1.41% of the total position.
      49Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 4,599 shares, the number of shares held increased 0.37% compared to the previous period and now represents 1.09% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 3,558 shares, the number of shares held increased 0.37% compared to the previous period and now represents 1.65% of the total position.
      33Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 1,974 shares, the number of shares held increased 0.37% compared to the previous period and now represents 1.75% of the total position.
      132Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 7,593 shares, the number of shares held increased 0.37% compared to the previous period and now represents 2.04% of the total position.
      51Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 24,222 shares, the number of shares held increased 5.23% compared to the previous period and now represents 2.08% of the total position.
      33Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 6,597 shares, the number of shares held increased 0.37% compared to the previous period and now represents 2.66% of the total position.
      36Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 3,180 shares, the number of shares held increased 0.37% compared to the previous period and now represents 2.41% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-08 07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 50,700 shares, the number of shares held increased 0.37% compared to the previous period and now represents 2.63% of the total position.
      753Comment
      Report
       
       
       
       

      Most Discussed